MARAVAI LIFESCIENCES HOLDINGS, INC.
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Daniel S. GoldmanHouse · D · NY |
MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. · Stock |
Sale $1,001 - $15,000 |
May 19, 2023 | Apr 10, 2023 | Filing ↗ |
Whale Activity
- Increased67
- New48
- Held26
- Decreased51
- Closed27
- No prior filing10
| Filer | Shares | Value | Change |
|---|---|---|---|
| GTCR LLC | 20.2M | $154.3M | held |
| BlackRock, Inc. | 10.6M | $80.9M | increased |
| MILLENNIUM MANAGEMENT LLC | 7.6M | $58.4M | increased |
| FMR LLC | 6.9M | $52.9M | increased |
| AMERIPRISE FINANCIAL INC | 5.8M | $44.7M | — |
| BRAIDWELL LP | 5.5M | $42.2M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.3M | $40.2M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 4.0M | $30.5M | decreased |
| 12 West Capital Management LP | 3.8M | $29.1M | decreased |
| WELLINGTON MANAGEMENT GROUP LLP | 3.7M | $28.1M | new |
| Nuveen, LLC | 3.5M | $26.7M | increased |
| First Eagle Investment Management, LLC | 3.3M | $25.1M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Brust BerndChief Executive Officer · Director | Tax withholding | −29.3K | $7.32 | $214K | Sep 8, 2026 | Form 4 ↗ |
| Asarpota RajeshChief Financial Officer | Tax withholding | −5,465 | $7.68 | $42K | Aug 31, 2026 | Form 4 ↗ |
| Brust BerndChief Executive Officer · Director | Tax withholding | −29.3K | $6.23 | $182K | Aug 10, 2026 | Form 4 ↗ |
| Asarpota RajeshChief Financial Officer | Tax withholding | −5,465 | $6.59 | $36K | Jul 30, 2026 | Form 4 ↗ |
| Brust BerndChief Executive Officer · Director | Tax withholding | −29.3K | $5.92 | $173K | Jul 8, 2026 | Form 4 ↗ |
| Asarpota RajeshChief Financial Officer | Tax withholding | −65.6K | $6.39 | $419K | Jun 30, 2026 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Sale | −25.0K | $5.10 | $127K | Jun 10, 2026 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Sale | −25.0K | $5.06 | $126K | Jun 9, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Gift | +46.3K | $0.00 | $0 | Jun 9, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Gift | −46.3K | $0.00 | $0 | Jun 9, 2026 | Form 4 ↗ |
| Brust BerndChief Executive Officer · Director | Tax withholding | −351.0K | $5.02 | $1.8M | Jun 8, 2026 | Form 4 ↗ |
| GRAY SUSANNAHDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| MARKER LUKE JOSEPHDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| CUNNINGHAM SEAN LAURENCEDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| DeFord John ADirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| MIHAS CONSTANTINE SDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Grant / award Amended | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Grant / award | +46.3K | $4.38 | $203K | May 26, 2026 | Form 4 ↗ |
| ECKERT R ANDREWDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Grant / award | +776 | $2.84 | $2K | May 15, 2026 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.7M | $23.1M | 0.00% | Jun 30, 2026 |
| First Eagle Small Cap Opportunity Fund First Eagle Funds | 3.2M | $21.3M | 0.73% | Jul 31, 2026 |
| iShares Russell 2000 ETF iShares Trust | 3.0M | $18.5M | 0.02% | Jun 30, 2026 |
| General American Investors Company, Inc. | 1.7M | $13.1M | 0.75% | Sep 30, 2026 |
| Columbia Small Cap Growth Fund COLUMBIA FUNDS SERIES TRUST I | 1.6M | $11.8M | 0.34% | Aug 31, 2026 |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 1.6M | $10.5M | 0.26% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.5M | $9.1M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 1.3M | $8.3M | 0.09% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1.2M | $8.1M | 0.02% | Jul 31, 2026 |
| Meridian Contrarian Fund Meridian Fund Inc | 1.3M | $8.0M | 1.17% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list MRVI's shares (CUSIP 56600D107), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
- Israel A. EnglanderSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
Sep 29, 2026 · ↗ - Millennium Group Management LLCSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
Sep 29, 2026 · ↗ - Millennium Management LLCSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
Sep 29, 2026 · ↗ - Joshua WoolSCHEDULE 13G/A · passive (13G) · 45.0K shares0.0%
Aug 13, 2026 · ↗ - Matthew BarkoffSCHEDULE 13G/A · passive (13G) · 290.1K shares0.2%
Aug 13, 2026 · ↗ - Stuart FeldmanSCHEDULE 13G/A · passive (13G) · 3.7M shares2.5%
Aug 13, 2026 · ↗ - JD Squared Capital II LLCSCHEDULE 13G/A · passive (13G) · 3.0M shares2.0%
Aug 13, 2026 · ↗ - JD Squared Holdings II LLCSCHEDULE 13G/A · passive (13G) · 3.0M shares2.0%
Aug 13, 2026 · ↗ - Hudson View Capital LLCSCHEDULE 13G/A · passive (13G) · 674.1K shares0.5%
Aug 13, 2026 · ↗ - Hudson View Holdings LLCSCHEDULE 13G/A · passive (13G) · 674.1K shares0.5%
Aug 13, 2026 · ↗
Corporate Lobbying
No lobbying filings found naming MARAVAI LIFESCIENCES HOLDINGS, INC. as the client.
Government Contracts
No federal contract awards found for MARAVAI LIFESCIENCES HOLDINGS, INC..
U.S. Patents
No USPTO patent applications found for MARAVAI LIFESCIENCES HOLDINGS, INC..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $185.7M | $259.2M | $288.9M | $883.0M | $799.2M |
| Operating income | -$215.3M | -$235.6M | -$31.6M | $574.2M | $554.6M |
| Net income | -$130.8M | -$144.8M | -$119.0M | $220.2M | $182.0M |
| Diluted EPS | -$0.90 | -$1.05 | -$0.90 | $1.67 | $1.56 |
| Operating cash flow | -$57.6M | $7.5M | $126.2M | $536.0M | $368.6M |
| Cash and equivalents | $216.9M | $322.4M | $575.0M | $632.1M | n/a |
| Total assets | $770.6M | $1.01B | $1.49B | $2.28B | $1.92B |
| Total liabilities | $397.9M | $431.0M | $697.6M | $1.38B | $1.37B |
| Shareholders' equity | $212.4M | $325.3M | $416.8M | $545.2M | $315.5M |
As MARAVAI LIFESCIENCES HOLDINGS, INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 26, 2026 ↗
Stock Splits
No stock splits in MRVI's price history.
Material Events (8-K)
- 8-K · Items 9.01Nov 4, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 1.01, 1.02, 2.03, 7.01, 9.01Material agreement · Termination of agreement · Direct financial obligationJun 3, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 29, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗

